首页> 外文期刊>Current stem cell research & therapy >Stem cell regenerative potential combined with nanotechnology and tissue engineering for myocardial regeneration.
【24h】

Stem cell regenerative potential combined with nanotechnology and tissue engineering for myocardial regeneration.

机译:干细胞的再生潜力与纳米技术和组织工程相结合,可进行心肌再生。

获取原文
获取原文并翻译 | 示例
           

摘要

The stem cell-based therapy for post-infarction myocardial regeneration has been introduced more than a decade ago, but the functional improvement obtained is limited due to the poor retention and short survival rate of transplanted cells into the damaged myocardium. More recently, the emerging nanotechnology concepts for advanced diagnostics and therapy provide promising opportunities of using stem cells for myocardial regeneration. In this paper will be provided an overview of the use of nanotechnology approaches in stem cell research for: 1) cell labeling to track the distribution of stem cells after transplantation, 2) nanoparticle-mediated gene delivery to stem cells to promote their homing, engraftment, survival and differentiation in the ischemic myocardium and 3) obtaining of bio-inspired materials to provide suitable myocardial scaffolds for delivery of stem cells or stem cell-derived factors.
机译:梗死后心肌再生的基于干细胞的疗法已经被引入了十多年,但是由于移植细胞进入受损心肌的滞留性差和存活率短,获得的功能改善受到限制。最近,用于高级诊断和治疗的新兴纳米技术概念提供了使用干细胞进行心肌再生的有希望的机会。本文将概述纳米技术在干细胞研究中的应用:1)细胞标记以追踪移植后干细胞的分布; 2)纳米粒子介导的基因递送至干细胞,以促进干细胞的归巢,植入,在缺血性心肌中的存活和分化以及3)获得受生物启发的材料,以提供合适的心肌支架来递送干细胞或干细胞来源的因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号